Enzene Biosciences Ltd. - Product Pipeline Review - 2016 Summary Global Markets Direct's, 'Enzene Biosciences Ltd. - Product Pipeline Review - 2016', provides an overview of the Enzene Biosciences Ltd.'s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by Enzene Biosciences Ltd., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data. Scope - The report provides a snapshot of the pipeline therapeutic landscape of Enzene Biosciences Ltd. - The report provides overview of Enzene Biosciences Ltd. including its business description, key facts, and locations and subsidiaries - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report assesses Enzene Biosciences Ltd.'s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report features Enzene Biosciences Ltd.'s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects Reasons To Buy - Evaluate Enzene Biosciences Ltd.'s strategic position with total access to detailed information on its product pipeline - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Enzene Biosciences Ltd. - Identify potential new clients or partners in the target demographic - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Enzene Biosciences Ltd.'s pipeline depth and focus of pipeline therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 4 Enzene Biosciences Ltd. Snapshot 5 Enzene Biosciences Ltd. Overview 5 Key Information 5 Key Facts 5 Enzene Biosciences Ltd. - Research and Development Overview 6 Key Therapeutic Areas 6 Enzene Biosciences Ltd. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Enzene Biosciences Ltd. - Pipeline Products Glance 10 Enzene Biosciences Ltd. - Early Stage Pipeline Products 10 Preclinical Products/Combination Treatment Modalities 10 Discovery Products/Combination Treatment Modalities 11 Enzene Biosciences Ltd. - Drug Profiles 12 Biosimilar 1 for Metabolic Disorders 12 Product Description 12 Mechanism of Action 12 R&D Progress 12 Biosimilar 1 for Oncology 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 Biosimilar 1 for Ophthalmological Disorders 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 Biosimilar 1 for Rheumatoid Arthritis 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 Biosimilar 2 for Metabolic Disorders 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 Biosimilar 2 for Oncology 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 Biosimilar 2 for Rheumatoid Arthritis 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 Biosimilar 3 for Hematological Disorders 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 Biosimilar 3 for Metabolic Disorders 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 Biosimilar 3 for Rheumatoid Arthritis 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 Biosimilar for Allergy 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 Enzene Biosciences Ltd. - Pipeline Analysis 23 Enzene Biosciences Ltd. - Pipeline Products by Molecule Type 23 Enzene Biosciences Ltd. - Locations And Subsidiaries 24 Head Office 24 Appendix 25 Methodology 25 Coverage 25 Secondary Research 25 Primary Research 25 Expert Panel Validation 25 Contact Us 25 Disclaimer 26
List of Tables
Enzene Biosciences Ltd., Key Information 5 Enzene Biosciences Ltd., Key Facts 5 Enzene Biosciences Ltd. - Pipeline by Indication, 2016 7 Enzene Biosciences Ltd. - Pipeline by Stage of Development, 2016 8 Enzene Biosciences Ltd. - Monotherapy Products in Pipeline, 2016 9 Enzene Biosciences Ltd. - Preclinical, 2016 10 Enzene Biosciences Ltd. - Discovery, 2016 11 Enzene Biosciences Ltd. - Pipeline by Molecule Type, 2016 23
List of Figures
Enzene Biosciences Ltd. - Pipeline by Indication, 2016 7 Enzene Biosciences Ltd. - Pipeline by Stage of Development, 2016 8 Enzene Biosciences Ltd. - Monotherapy Products in Pipeline, 2016 9 Enzene Biosciences Ltd. - Pipeline by Molecule Type, 2016 23
Global data center UPS market size is estimated to reach USD 5.7 billion by 2020, as per a new research report by Radiant Insights, Inc. Declining tolerance levels pertaining to data loss along with amplifying acceptance of cloud computing is likelyRead More...
Global air traffic control equipment market is projected to reach USD 4.2 billion by 2020, as per a new research report by Radiant Insights, Inc. Mounting price sensitivity among customers with introduction of low fare airlines is expected to drive tRead More...
Global LCP (Liquid Crystal Polymer) industry is forecasted to reach USD 1.23 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing trend towards developing militarized components and connectors are likely to drive the demandRead More...
Global Automated Test Equipment (ATE) market is expected to be valued at USD 4.48 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing design complexity coupled with need for effective testing is expected to drive the glRead More...
Global engineering service outsourcing market size is likely to be valued at USD 415.7 billion by 2020, as per a new research report by Radiant Insights, Inc. Rapid alignment of OEMs accompanied by increasing focus on efficient performance and reliabRead More...
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.